Latest News

  • TECHNOLOGY

    18 Feb 2026

    How the Cloud Powers the Next mRNA Breakthrough

  • INSIGHTS

    16 Feb 2026

    Can Europe Win the mRNA Cancer Race?

  • REGULATORY

    12 Feb 2026

    FDA Refusal-to-File Resets mRNA Flu Strategy

  • INNOVATION

    11 Feb 2026

    Britain’s Bet On Better RNA Factories

Moderna and Recordati Bet on mRNA Beyond Vaccines

Syringe labeled Moderna mRNA-3927 with Recordati logo in background

PARTNERSHIPS

10 Feb 2026

Moderna and Recordati partner on an mRNA therapy for propionic acidemia, combining resources to accelerate development

Researcher analyzing mRNA samples in biotech lab

TECHNOLOGY

18 Feb 2026

How the Cloud Powers the Next mRNA Breakthrough

Biotech firms are using cloud platforms to accelerate mRNA research while managing compliance, security, and rising costs

Medical syringe containing mRNA vaccine held by healthcare worker in gloves

INSIGHTS

16 Feb 2026

Can Europe Win the mRNA Cancer Race?

A €6.9 million EU grant backs eTheRNA’s cancer vaccines and signals Europe’s long-term bet on mRNA oncology

Gloved hand preparing vaccine dose from vial

REGULATORY

12 Feb 2026

FDA Refusal-to-File Resets mRNA Flu Strategy

Agency’s decision signals tougher trial standards for seasonal vaccine approvals as pandemic-era flexibility recedes  

Laboratory technician working on RNA biomanufacturing equipment

INNOVATION

11 Feb 2026

Britain’s Bet On Better RNA Factories

As saRNA advances in 2026, CPI’s RNA infrastructure is reinforcing the UK’s role in Europe’s evolving vaccine manufacturing landscape

Syringe labeled Moderna mRNA-3927 with Recordati logo in background

PARTNERSHIPS

10 Feb 2026

Moderna and Recordati Bet on mRNA Beyond Vaccines

Moderna and Recordati partner on an mRNA therapy for propionic acidemia, combining resources to accelerate development

mRNA vaccine vial on medical documents with pills, syringe, and stethoscope

MARKET TRENDS

5 Feb 2026

mRNA Deals Push the Industry Beyond Vaccines

Big acquisitions and delivery breakthroughs signal mRNA’s shift from pandemic speed to precision therapies

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.